Company: PTHS
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001753926-25-001326
Chunk: 78

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 78
---
 Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

    10.16
     
    Purchase and Sale Agreement, dated as of July 1, 2025, by and among Channel Therapeutics Corporation and Channel Pharmaceutical Corporation, as the Seller Parties and Nomis RoyaltyVest LLC, Ligand Pharmaceuticals Incorporated and Madison Royalty LLC, as the Purchasers. (filed as Exhibit 10.13 to Registrant’s Current Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

    10.17
     
    Executive Employment Agreement, dated July 1, 2025, between Pelthos Therapeutics Inc. and Scott Plesha. (filed as Exhibit 10.17 to Registrant’s Current Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

    10.18
     
    Executive Employment Agreement, dated July 1, 2025, between Pelthos Therapeutics Inc. and Francis Knuettel II. (filed as Exhibit 10.18 to Registrant’s Current Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

    10.19
     
    Executive Employment Agreement, dated July 1, 2025, between Pelthos Therapeutics Inc. and Sai Rangarao. (filed as Exhibit 10.19 to Registrant’s Current Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

    10.20
     
    Employee Lease Agreement, dated July 1, 2025, by and between Ligand Pharmaceuticals Incorporated and Pelthos Therapeutics Inc. (filed as Exhibit 10.20 to Registrant’s Current Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

48 

    10.21
     
    Transition Services Agreement, dated July 1, 2025, by and between Ligand Pharmaceuticals Incorporated and LNHC, Inc. (filed as Exhibit 10.21 to Registrant’s Current Report on Form 8-K, filed with the SEC on July 1, 2025 and incorporated by reference herein).

    10